Pirfenidone Tablet
Product Images NDC 59651-238

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 59651-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Fig1)

A cumulative distribution plot showing percentage of patients by change in percent predicted forced vital capacity (FVC) from baseline to Week 52. The graph compares Pirfenidone (n=278) and placebo (n=277) groups, illustrating worsening (decrease in %FVC) versus no decline (increase in %FVC) with dashed lines marking ≥10% and ≥0% decline thresholds.*

FDA Label Image

Figure 2 (Pirfenidone Fig2)

Line graph titled 'Mean Change from Baseline in Forced Vital Capacity (Study 1)' displaying mean change in FVC (mL) over 52 weeks. Two lines compare Pirfenidone (n=278) and Placebo (n=277), showing a decline in FVC over time for both groups, with the Pirfenidone group experiencing less decline.*

FDA Label Image

Figure 3 (Pirfenidone Fig3)

A Kaplan-Meier survival curve chart comparing all-cause mortality between Pirfenidone and Placebo groups over approximately 120 weeks. The y-axis represents the percentage of patients alive, and the x-axis shows time in weeks. Patient numbers at risk are listed below the x-axis at various time points. The chart includes a hazard ratio with confidence interval for the comparison.*

FDA Label Image

Figure 4 (Pirfenidone Fig4)

A dosing schedule table for Pirfenidone Tablets 267 mg showing the number of tablets taken during morning, afternoon, and evening across three time periods: days 1 to 7, days 8 to 14, and from day 15 onward. The total daily pills increase from 3 to 6, then to 9 tablets per day.*

FDA Label Image

Figure 5 (Pirfenidone Fig5)

A dosing schedule table for Pirfenidone Tablets 801 mg showing the number of tablets to be taken each day starting from day 15 onward. It specifies one tablet in the morning (breakfast), one in the afternoon (lunch), and one in the evening (dinner), totaling three pills per day.*

FDA Label Image

Package Label-principal Display Panel (267 mg (90 Tablets Container Label))

Label for Pirfenidone Tablets, USP, 267 mg oral tablets by Aurobindo Pharma Limited. The label indicates a carton of 90 tablets, with storage instructions between 20° to 25°C. It includes distributor information for Aurobindo Pharma USA, Inc., located in East Windsor, NJ, and a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (267 mg [270 Tablets (3 bottles of 90 each) Container Carton Label])

The carton label for Pirfenidone Tablets, USP 267 mg oral tablet, distributed by Aurobindo Pharma USA, Inc. The package contains 270 tablets in three bottles of 90 tablets each. The label includes storage instructions, a caution to keep out of reach of children, and is marked Rx only. The NDC is 59651-238-27.*

FDA Label Image

Package Label-principal Display Panel (801 mg (90 Tablets Container Label))

Pirfenidone Tablets, USP 801 mg oral tablets label by Aurobindo Pharma USA, Inc., containing 90 tablets. The label shows the NDC 59651-239-90, dosage strength of 801 mg per tablet, storage instructions, and manufacturer details including the address in East Windsor, NJ, and that the product is made in India.*

FDA Label Image

Package Label-principal Display Panel (801 mg (90 Tablets Container Carton Label))

Carton packaging for Pirfenidone Tablets, USP 801 mg oral tablets by Aurobindo Pharma USA, Inc. The box contains 90 tablets with NDC 59651-239-90 and notes storage at 20° to 25°C. The label emphasizes keeping out of reach of children and indicates Rx only. Made in India with distributor address in East Windsor, NJ.*

FDA Label Image

Chemical Structure (Pirfenidone Str)

Chemical structure of Pirfenidone shown as a diagram with two benzene rings connected through a nitrogen atom, including a methyl group and a carbonyl group attached to one ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.